BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18021962)

  • 1. Long-term results of kidney transplantation from HCV-positive donors.
    Kasprzyk T; Kwiatkowski A; Wszola M; Ostrowski K; Danielewicz R; Domagala P; Malkowski P; Fesolowicz S; Nosek R; Czerwinski J; Trzebicki J; Durlik M; Paczek L; Patrzalek D; Rowinski W; Chmura A
    Transplant Proc; 2007 Nov; 39(9):2701-3. PubMed ID: 18021962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of kidneys from HCV-positive donors: a safe strategy?
    Fabrizi F; Bunnapradist S; Lunghi G; Martin P
    J Nephrol; 2003; 16(5):617-25. PubMed ID: 14733406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV.
    Minz M; Sharma A; Das A; Chawla Y
    Transplant Proc; 2008 Sep; 40(7):2386-8. PubMed ID: 18790242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of renal allograft in Turkish patients with pretransplantation hepatitis C virus infection.
    Unal E; Turkmen F; Sevinc C; Kiziler AR; Aydemir B; Titiz I
    Transplant Proc; 2006 Dec; 38(10):3448-50. PubMed ID: 17175299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should kidneys from older cadaveric donors be age-matched to the recipient?
    Foss A; Tuvin D; Leivestad T; Øyen O; Bentdal Ø
    Transplant Proc; 2005 Oct; 37(8):3280-2. PubMed ID: 16298572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of kidney transplantation in patients with hepatitis C virus infection.
    Huo TI; Yang WC; Wu JC; King KL; Lin CY; Loong CC; Lui WY; Chang FY; Lee SD
    Hepatogastroenterology; 2001; 48(37):169-73. PubMed ID: 11268958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation.
    Manga Sahin G; Sahin S; Kantarci G; Ergin H
    Transplant Proc; 2006 Mar; 38(2):499-501. PubMed ID: 16549159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation from old donors into HCV and non-HCV recipients.
    Baccarani U; Adani GL; Toniutto P; Sainz M; Lorenzin D; Viale PL; Ramacciato G; Risaliti A; Bresadola F
    Transplant Proc; 2004 Apr; 36(3):527-8. PubMed ID: 15110581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V; Ingsathit A; Jirasiritham S
    Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney transplantation from donors with viral B and C hepatitis.
    Veroux P; Veroux M; Sparacino V; Giuffrida G; Puliatti C; Macarone M; Fiamingo P; Cappello D; Gagliano M; Spataro M; Di Mare M; Cannizzaro MA; Severino V
    Transplant Proc; 2006 May; 38(4):996-8. PubMed ID: 16757242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of donor age on the results of liver transplantation in hepatitis C virus-positive recipients.
    Pérez-Daga JA; Ramírez-Plaza C; Suárez MA; Santoyo J; Fernández-Aguilar JL; Aranda JM; Sánchez-Pérez B; González-Sánchez A; Alvárez A; Valle M; Bondía JA
    Transplant Proc; 2008 Nov; 40(9):2959-61. PubMed ID: 19010159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome.
    Berber I; Aydin C; Yigit B; Turkmen F; Titiz IM; Altaca G
    Transplant Proc; 2005 Dec; 37(10):4173-5. PubMed ID: 16387070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
    Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney transplantation from hepatitis C virus-positive donors into hepatitis C virus-positive recipients: a safe way to expand the donor pool?
    Veroux P; Veroux M; Puliatti C; Cappello D; Macarone M; Gagliano M; Fiamingo P; Di Mare M; Spataro M; Ginevra N
    Transplant Proc; 2005; 37(6):2571-3. PubMed ID: 16182747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival of recipients of liver grafts from donors older than 80 years: is it achievable?
    Cescon M; Grazi GL; Ercolani G; Nardo B; Ravaioli M; Gardini A; Cavallari A
    Liver Transpl; 2003 Nov; 9(11):1174-80. PubMed ID: 14586878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of hepatitis C virus on renal transplantation: association with poor survival.
    Pedroso S; Martins L; Fonseca I; Dias L; Henriques AC; Sarmento AM; Cabrita A
    Transplant Proc; 2006; 38(6):1890-4. PubMed ID: 16908314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of renal transplantation from marginal donors.
    Collini A; De Bartolomeis C; Ruggieri G; Barni R; Bernini M; Carmellini M
    Transplant Proc; 2006 Dec; 38(10):3398-9. PubMed ID: 17175283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate-term outcomes of hepatitis C-positive compared with hepatitis C-negative deceased-donor renal allograft recipients.
    Brown KL; El-Amm JM; Doshi MD; Singh A; Morawski K; Cincotta E; Siddiqui F; Losanoff JE; West MS; Gruber SA
    Am J Surg; 2008 Mar; 195(3):298-302; discussion 302-3. PubMed ID: 18190891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.